Journal article
The impact of empagliflozin on kidney injury molecule-1: A subanalysis of the Effects of Empagliflozin on Cardiac Structure, Function, and Circulating Biomarkers in Patients with Type 2 Diabetes CardioLink-6 trial
E Opingari, S Verma, KA Connelly, CD Mazer, H Teoh, A Quan, F Zuo, Y Pan, DL Bhatt, B Zinman, LA Leiter, AT Yan, DZI Cherney, RE Gilbert
Nephrology Dialysis Transplantation | OXFORD UNIV PRESS | Published : 2020
DOI: 10.1093/ndt/gfz294
Grants
Funding Acknowledgements
This trial was supported by an unrestricted investigatorinitiated study grant from Boehringer Ingelheim to S.V. and B.Z.